CDC en Español

Search:

ISSN: 1080-6059

  • Email this page

Volume 14, Number 12–December 2008

CME ACTIVITY

Clinical Characteristics and Molecular Subtyping of Vibrio vulnificus Illnesses, Israel

Medscape, LLC is pleased to provide online continuing medical education (CME) for this journal article, allowing clinicians the opportunity to earn CME credit. Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide CME for physicians. Medscape, LLC designates this educational activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. All other clinicians completing this activity will be issued a certificate of participation. To participate in this journal CME activity: (1) review the learning objectives and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation at http://www.medscape.com/cme/eid; (4) view/print certificate.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • List the predisposing factors for infections caused by Vibrio vulnificus biotypes 1 and 2.
  • Identify the differences between infections caused by V. vulnificus biotypes 1 and 2 and biotype 3.
  • Describe the types of fish associated with V. vulnificus biotype 3 infection.
  • Describe the mortality associated with V. vulnificus biotype 3 infection.
  • List the predictors of mortality in V. vulnificus biotype 3 infection.

CME Editor

Beverly Merritt, Technical Writer-Editor, Emerging Infectious Diseases. Disclosure: Beverly Merritt has disclosed no relevant financial relationships.

CME Author

Désirée Lie, MD, MSEd, Clinical Professor, Family Medicine, University of California, Orange; Director, Division of Faculty Development, UCI Medical Center, Orange, California. Disclosure: Désirée Lie, MD, MSEd, has disclosed no relevant financial relationships.

Authors

Disclosures: Ronit Zaidenstein, MD; Chantal Sadik, MD; Larisa Lerner, MD; Lea Valinsky, PhD; June Kopelowitz, PhD; Ruth Yishai, PhD; Vered Agmon, PhD; Michele Parsons, MS; Cheryl Bopp, MS; and Miriam Weinberger, MD, have disclosed no relevant financial relationships.

Click here to continue to article

Comments to the EID Editors

Please contact the EID Editors at eideditor@cdc.gov

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.

This page posted November 24, 2008

Safer Healthier People

Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, U.S.A
Tel: (404) 639-3311 / Public Inquiries: (404) 639-3534 / (800) 311-3435